AbbVie (ABBV) looks to new drugs to boost sales following Humira competition - WSJ

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. DFTX
7. APGE
8. LLY
9. RGNX
10. LCO

Go back to AbbVie (ABBV) looks to new drugs to boost sales following Humira competition - WSJ
AbbVie (NYSE: ABBV) Delayed: 232.00 +15.51 (7.16%)
Previous Close $216.49    52 Week High $68.12 
Open $221.94    52 Week Low $50.71 
Day High $232.15    P/E 50.33 
Day Low $221.94    EPS $4.61 
Volume 3,778,661